Seelos therapeutics announces amendment of sls-002 agreement

Seelos therapeutics announces amendment of sls-002 agreement.seelos therapeutics inc - seelos plans to study sls-002 initially in suicidality in major depressive disorder.seelos therapeutics inc - amendment of agreement with vyera pharmaceuticals for development of sls-002.seelos therapeutics inc - amendment now removes requirement to conduct a phase iii trial.seelos therapeutics - converts one-time cash payment obligation otherwise owed to vyera for commencement of phase iii trial to cash and stock payments.
SEEL Ratings Summary
SEEL Quant Ranking